Updated Date:
20 Feb 2026
Product Detail:
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials
Shortage Status:
Anticipated
AUST R:
203313
Availability:
Available
Active Ingredient:
clevidipine
Reason:
Transport / Logistic issues / Storage capacity issues
Dosage Form:
Injection,emulsion
Supply Impact Dates
From 01 Mar 2026
To 31 Jul 2026
Management Action:
The TGA is currently investigating management actions. Alternative unapproved products may be available under the Special Access Scheme.
